Butyric Acid

Butyric Acid

SCHEMBL1245758

CC(O)CO.CCCC(=O)O

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Butyric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.65
HDAC3 O15379 1/20 0.65
HDAC1 Q13547 1/20 0.65
HDAC2 Q92769 1/20 0.65
HDAC8 Q9BY41 1/20 0.65
TDP1 Q9NUW8 3/20 0.50
AKR1B1 P15121 1/20 0.44
GPR84 Q9NQS5 7/20 0.42
PPARG P37231 7/20 0.42
PPARD Q03181 7/20 0.42
PPARA Q07869 7/20 0.42
HDAC11 Q96DB2 5/20 0.42
TSHR P16473 4/20 0.42
PTPN1 P18031 3/20 0.42
ALDH1A1 P00352 2/20 0.42
TLR2 O60603 2/20 0.42
FABP4 P15090 2/20 0.42
FFAR1 O14842 2/20 0.42
FFAR4 Q5NUL3 2/20 0.42
SLC22A6 Q4U2R8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyric Acid SCHEMBL28251629 1.00 FFAR3 (0.65) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL359821 1.00 FFAR3 (0.65) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL29707583 0.95 FFAR3 (0.59) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL181413 0.95 FFAR3 (0.59) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL181872 0.95 FFAR3 (0.59) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL2254618 0.93 FFAR3 (0.56) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL7038038 0.89 FFAR3 (0.52) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL10901312 0.87 FFAR3 (0.68) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL8159821 0.87 FFAR3 (0.68) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL4578587 0.87 FFAR3 (0.77) FFAR3HDAC3HDAC1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260102368-A1 NOVEL FEED ADDITIVES COMPRISING FATTY ACID ESTERS AND RELATED METHODS TO IMPROVE ANIMAL GROWTH PERFORMANCE AND HEALTH KEMIN INDUSTRIES, INC. (US) 2026-04-16 US claimed
CN-113980252-B Continuous production method of modified poly (butylene succinate) 上海师范大学 2023-09-01 CN claimed
CN-113980252-A Continuous production method of modified poly (butylene succinate) 上海师范大学 2022-01-28 CN claimed
CN-106873309-A A kind of Positive photosensitive water solubility dry film solder mask and purposes 浙江福斯特新材料研究院有限公司 2017-06-20 CN claimed
US-9470978-B2 Solution composition for passivation layer, thin film transistor array panel, and manufacturing method for thin film transistor array panel SAMSUNG DISPLAY CO., LTD. (KR) 2016-10-18 US claimed
CN-105542124-A Alkaline-water soluble light-cured resin and preparation method thereof SHENZHEN RONGDA PHOTOSENSITIVE SCIENCE & TECH CO LTD 2016-05-04 CN claimed
US-9188867-B2 Solution composition for passivation layer, thin film transistor array panel, and manufacturing method for thin film transistor array panel SAMSUNG DISPLAY CO., LTD. (KR) 2015-11-17 US claimed
US-20150050597-A1 SOLUTION COMPOSITION FOR PASSIVATION LAYER, THIN FILM TRANSISTOR ARRAY PANEL, AND MANUFACTURING METHOD FOR THIN FILM TRANSISTOR ARRAY PANEL SAMSUNG DISPLAY CO LTD (KR) 2015-02-19 US claimed
US-8592621-B2 Precursor compounds of sweet taste receptor antagonists for the prevention or treatment of disease SYMRISE AG (DE) 2013-11-26 US claimed
US-20130099228-A1 SOLUTION COMPOSITION FOR PASSIVATION LAYER, THIN FILM TRANSISTOR ARRAY PANEL, AND MANUFACTURING METHOD FOR THIN FILM TRANSISTOR ARRAY PANEL SAMSUNG DISPLAY CO., LTD. (KR) 2013-04-25 US claimed
US-20110045069-A1 PRECURSOR COMPOUNDS OF SWEET TASTE RECEPTOR ANTAGONISTS FOR THE PREVENTION OR TREATMENT OF DISEASE SYMRISE GMBH CO. KG (DE) 2011-02-24 US claimed
US-20260102368-A1 NOVEL FEED ADDITIVES COMPRISING FATTY ACID ESTERS AND RELATED METHODS TO IMPROVE ANIMAL GROWTH PERFORMANCE AND HEALTH KEMIN INDUSTRIES, INC. (US) 2026-04-16 US disclosed
EP-4633581-A1 A TOPICAL COMPOSITION Rock & Herb Pte Ltd (SG) 2025-10-22 EP disclosed
US-20240410055-A1 METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS MERCK PATENT GMBH (DE) 2024-12-12 US disclosed
US-20240277012-A1 DUPLICATE BEVERAGE WANG JIE (US) 2024-08-22 US disclosed
US-5504068-A DISSOLVED IN ORGANIC SOLVENT WITH A SKIN PENETRATION ENHANCER CONSISTING OF ALKANOLAMINES AND MONOVALENT ALCOHOL ESTERS OF MYRISTIC, ADIPIC AND SEBACIC ACIDS LTT INSTITUTE CO., LTD. (JP) 1996-04-02 US disclosed
EP-0615520-A1 OPTICALLY ACTIVE LACTONES GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) 1994-09-21 EP disclosed
EP-0547229-A1 EXTERNAL PREPARATION CONTAINING CYCLOSPORIN LTT INSTITUTE CO., LTD. (JP) 1993-06-23 EP disclosed
US-4808443-A COATING THIN FILM ON WET SURFACE RIGHT AFTER PRINTING SAKATA SHOKAI, LTD. (JP) 1989-02-28 US disclosed
EP-0063037-B1 ADHESIVE COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-09-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260102368-A1 NOVEL FEED ADDITIVES COMPRISING FATTY ACID ESTERS AND RELATED METHODS TO IMPROVE ANIMAL GROWTH PERFORMANCE AND HEALTH FABP2, VIP, SLC27A2 FFAR3 24/4885HDAC3 2730/4885HDAC1 3116/4885
US-20110045069-A1 PRECURSOR COMPOUNDS OF SWEET TASTE RECEPTOR ANTAGONISTS FOR THE PREVENTION OR TREATMENT OF DISEASE TAS1R2, TAS2R5, TAS2R1 FFAR3 163/4885HDAC3 2442/4885HDAC1 2340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.